The effects of statins on endothelium, inflammation and cardioprotection

被引：28

作者：

Elrod, JW ^{[1
]}

Lefer, DJ ^{[1
]}

机构：

[1] Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71130 USA

来源：

DRUG NEWS & PERSPECTIVES | 2005年 / 18卷 / 04期

关键词：

D O I：

10.1358/dnp.2005.18.4.908656

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The advent of HMG-CoA reductase inhibitors (i.e., statins) has greatly impacted the treatment of cardiovascular disease. Statins were originally developed as lipid-lowering drugs to combat high-cholesterol and attenuate coronary artery disease. Wide-ranging clinical and basic science investigations have now suggested that statins may provide beneficial effects outside of reductions in low-density lipoprotein and triglycerides. These cholesterol-independent actions have been found to downregulate vascular inflammation and promote cardioprotection against ischemic disorders and heart failure. Mechanisms of this protection include increases in endothelial nitric oxide synthase activity and a subsequent rise in nitric oxide bioavailability. This review will encompass clinical and basic science research of statin-mediated cardiovascular protection. (c) 2005 Prous Science. All rights reserved.

引用

页码：229 / 236

页数：8

共 87 条

[1] The role of C-reactive protein in cardiovascular disease risk [J].

Albert M.A. ;

Ridker P.M. .

Current Cardiology Reports, 1999, 1 (2) :99-104

[2] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].

ALBERTS, AW ;

CHEN, J ;

KURON, G ;

HUNT, V ;

HUFF, J ;

HOFFMAN, C ;

ROTHROCK, J ;

LOPEZ, M ;

JOSHUA, H ;

HARRIS, E ;

PATCHETT, A ;

MONAGHAN, R ;

CURRIE, S ;

STAPLEY, E ;

ALBERSSCHONBERG, G ;

HENSENS, O ;

HIRSHFIELD, J ;

HOOGSTEEN, K ;

LIESCH, J ;

SPRINGER, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961

[3]

Balligand J L, 2002, Bull Mem Acad R Med Belg, V157, P427

[4] Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction [J].

Bauersachs, J ;

Galuppo, P ;

Fraccarollo, D ;

Christ, M ;

Ertl, G .

CIRCULATION, 2001, 104 (09) :982-985

[5] Simvastatin promotes atherosclerotic plaque stability in ApoE-deficient mice independently of lipid lowering [J].

Bea, F ;

Blessing, E ;

Bennett, B ;

Levitz, M ;

Wallace, EP ;

Rosenfeld, ME .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (11) :1832-1837

[6] EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .3. EFFICACY IN MODIFYING LIPOPROTEINS AND IMPLICATIONS FOR MANAGING PATIENTS WITH MODERATE HYPERCHOLESTEROLEMIA [J].

BRADFORD, RH ;

SHEAR, CL ;

CHREMOS, AN ;

FRANKLIN, FA ;

NASH, DT ;

HURLEY, DP ;

DUJOVNE, CA ;

POOL, JL ;

SCHNAPER, H ;

HESNEY, M ;

LANGENDORFER, A .

AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S18-S24

[7] Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins [J].

Brouet, A ;

Sonveaux, P ;

Dessy, C ;

Moniotte, S ;

Balligand, JL ;

Feron, O .

CIRCULATION RESEARCH, 2001, 89 (10) :866-873

[8] CHRONIC INHIBITION OF NITRIC-OXIDE PRODUCTION ACCELERATES NEOINTIMA FORMATION AND IMPAIRS ENDOTHELIAL FUNCTION IN HYPERCHOLESTEROLEMIC RABBITS [J].

CAYATTE, AJ ;

PALACINO, JJ ;

HORTEN, K ;

COHEN, RA .

ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05) :753-759

[9] Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention [J].

Chan, AW ;

Bhatt, DL ;

Chew, DP ;

Quinn, MJ ;

Moliterno, DJ ;

Topol, EJ ;

Ellis, SG .

CIRCULATION, 2002, 105 (06) :691-696

[10] Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass [J].

Chello, M ;

Carassiti, M ;

Agrò, F ;

Mastroroberto, P ;

Pugliese, G ;

Colonna, D ;

Covino, E .

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2004, 18 (05) :605-609

← 1 2 3 4 5 6 7 8 9 →